Risk of Sensory Deficits Drops With Rising Gestational Age

Share this content:
Risk of Sensory Deficits Drops With Rising Gestational Age
Risk of Sensory Deficits Drops With Rising Gestational Age

WEDNESDAY, July 18, 2018 (HealthDay News) -- Compared to full-term children, there is an increased incidence of hearing loss and visual impairment among moderately- and late-preterm infants, according to a study published online July 17 in Pediatrics.

Mikko Hirvonen, M.D., from the Central Finland Health Care District in Jyväskylä, and colleagues compared the incidences of sensory impairments among very-preterm (VP; <32 + 0/7 weeks), moderately-preterm (MP; 32 + 0/7 to 33 + 6/7 weeks), late-preterm (LP; 34 + 0/7 to 36 + 6/7 weeks), and term infants (≥37 weeks) using data from a national registry (1,018,256 infants).

The researchers found that the incidences of sensory impairments decreased with advancing gestational age at birth (P < 0.001). Intracranial hemorrhage and convulsions were associated with increased risks of hearing loss and visual impairment. There was an increased risk of hearing loss with VP (odds ratio [OR], 2.34) and LP (OR, 1.26) births, as well as an increased risk of visual impairment with VP (OR, 1.94), MP (OR, 1.42), and LP (OR, 1.31) births.

"MP and LP groups constitute the majority of all prematurely born children, and impairments among these groups constitute a major burden to society and the health care system," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »